New drug tested in healthy people – no cure expected
Knowledge-focused
Not yet recruiting
This early-stage study tests the safety of a new drug called migaldendranib in 36 healthy volunteers. Participants receive weekly injections, and researchers monitor for side effects and how the drug moves through the body. The goal is to gather safety information, not to treat a…
Phase: PHASE1 • Sponsor: Ashvattha Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC